Trending

    Purdue Pharma sentenced to pay $5.5 billion and dissolved amid opioid crisis settlement

    Moderate5 articles covering this·6 news sources·Updated 2 hours ago·World
    Share:

    Here's what it means for you.

    This landmark ruling signals a shift towards greater accountability in the pharmaceutical industry.

    What happened

    Purdue Pharma has been sentenced to pay $5.5 billion and will be dissolved as part of a settlement related to the opioid crisis.

    The Context

    • Purdue Pharma's aggressive marketing of OxyContin has been linked to the opioid epidemic in the United States.
    • The settlement will allow billions of dollars to flow to affected cities and states.
    • A new company will be established to focus on public health initiatives related to opioids.

    Takeaway

    The dissolution of Purdue Pharma and the establishment of a new company signal a shift towards accountability and public health in the pharmaceutical industry.

    This article was generated by AI from 5 verified sources and reviewed by A47 editorial systems.

    5 Articles
    International Business Times

    Purdue Pharma Faces $5.5B Criminal Sentence for Deceiving Regulators and Boosting Opioid Sales

    Purdue Pharma has been sentenced to pay $5.5 billion after pleading guilty to deceiving regulators and engaging in aggressive sales practices that contributed to the opioid crisis in the United States. This significant financial penalty follows years...

    15 hours ago
    Read Full Article
    The Guardian

    Purdue Pharma to be dissolved as judge approves criminal sentence in opioid case

    Purdue Pharma, the maker of OxyContin, is set to be dissolved and replaced by a new company focused on addressing the opioid crisis, following a federal judge's approval of a criminal sentence related to a US Department of Justice investigation. This...

    Investing.com

    Purdue Pharma receives $5.5 billion sentence, paving way for opioid settlement

    Purdue Pharma has been sentenced to pay $5.5 billion as part of a settlement related to its involvement in the opioid crisis, which has resulted in numerous lawsuits against the company. This ruling is a significant step in addressing the legal and f...

    Dow Jones – Health

    A federal judge sentenced OxyContin-maker Purdue Pharma to pay the government $225 million, ending a yearslong criminal case involving the company accused of fueling the opioid epidemic

    Purdue Pharma has been ordered to pay $225 million to the U.S. Justice Department, concluding a lengthy criminal case linked to the company's role in the opioid epidemic. This ruling allows Purdue to finalize a settlement related to numerous lawsuits...

    The Wall Street Journal

    Purdue Pharma to Pay $225 Million to Justice Department

    Purdue Pharma has been ordered to pay $225 million to the U.S. Justice Department, concluding a lengthy criminal case linked to the company's role in the opioid epidemic. This ruling allows Purdue to finalize a settlement related to numerous lawsuits...

    Financial Times

    Purdue Pharma to pay more than $8bn to end US opioid case

    Purdue Pharma has agreed to pay more than $8 billion to resolve a significant opioid case in the United States, a move that is expected to provide much-needed financial support to cities and states affected by the opioid epidemic. This resolution fol...